ASSURE Wearable ECG vs AVIEW
AI Verdict
Choose ASSURE Wearable ECG if…
Choose ASSURE Wearable ECG if you need continuous, real-time heart rate monitoring and event detection for at-risk cardiac patients in an ambulatory setting. This tool is ideal for identifying transient cardiac events that might be missed by intermittent monitoring, providing clinicians with immediate alerts and comprehensive physiologic trend data for timely intervention.
View ASSURE Wearable ECG →Choose AVIEW if…
Choose AVIEW if your practice requires an AI-powered platform to enhance the precision and efficiency of diagnosing and monitoring lung conditions and coronary artery calcification from CT scans. This solution is best suited for radiologists and pulmonologists seeking automated analysis for lung nodules, emphysema, and coronary artery calcium scoring, along with streamlined workflow integration.
View AVIEW →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | ASSURE Wearable ECG | AVIEW |
|---|---|---|
| Pricing | Unknown | Subscription; one-off payment |
| Deployment | The ASSURE system is intended for use by a patient during their normal daily activities primarily in the home or community setting, but also hospitals, medical clinics, healthcare facilities and transport. | Cloud-based; Hybrid solution; Locally on dedicated hardware; Locally virtualized (virtual machine, Docker) |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Unknown | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
AVIEWTool B, AVIEW, demonstrates superior usability for its target audience by significantly streamlining radiology workflows, with clinical validation showing 89% faster case throughput and a 60% reduction in interpretation time. Its integration with existing PACS/RIS/CIS systems and comprehensive reporting features enhance efficiency for radiologists.
Clinical Value
AVIEWAVIEW offers comprehensive AI-driven solutions for early detection, diagnosis, and monitoring of multiple thoracic conditions, including lung cancer, COPD, and coronary artery calcification, enhancing diagnostic precision. Its widespread adoption as a standard AI platform in national lung cancer screening programs across Europe and integration into major U.S. medical centers underscores its proven clinical impact and value.
Pricing & Value
AVIEWTool B, AVIEW, offers greater transparency in its pricing model, specifying options for subscription or one-off payments based on the number of installations and users. In contrast, Tool A, ASSURE Wearable ECG, only states 'contact for pricing,' providing less clarity for potential buyers.
Enterprise Readiness
AVIEWAVIEW demonstrates higher enterprise readiness through its flexible deployment options (cloud, hybrid, local, virtualized) and explicit integration capabilities with PACS/RIS/CIS. Its extensive global adoption, having processed over 2.5 million cases across 19 countries and being validated against IHE and FHIR standards, indicates robust scalability and proven integration within diverse healthcare ecosystems.
Innovation
AVIEWAVIEW's innovation lies in its comprehensive, multi-disease AI platform that integrates various analyses for thoracic CT imaging (lung nodules, COPD, CAC, ILD) into a single, streamlined workflow. This represents a significant 'paradigm shift from task-specific tools to an integrated diagnostic ecosystem' in radiology AI, offering a more holistic approach to diagnosis.
Support & Docs
ASSURE Wearable ECGTool A, ASSURE Wearable ECG, explicitly mentions that a 'Kestra patient service representative (PSR) fits and trains the patient on proper use and care of the system,' indicating a structured support mechanism for its end-users. While Tool B is widely adopted, the provided information does not detail its specific support or documentation offerings for clinicians or administrators.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | ASSURE Wearable ECG | AVIEW |
|---|---|---|
| Name | ASSURE Wearable ECG | AVIEW |
| Company | Kestra Medical Technologies | Coreline Soft Co. |
| Description | A non-therapeutic device for continuous heart rate monitoring and data collection, integrated into their digital healthcare platform for at-risk cardiac patients. | AI platform offering comprehensive solutions for the early detection, diagnosis, and monitoring of lung cancer, COPD, and coronary artery calcification from CT scans, enhancing diagnostic precision and streamlining radiology workflows. |
| Categories | Cardiology AI, Wearables & Remote Monitoring (RPM) | Cardiology AI, Oncology AI, Radiology & Imaging AI |
| Specialties | Cardiology | Cardiology, Pulmonology, Radiology |
Videos
Demos, reviews, and walkthroughs featuring ASSURE Wearable ECG and AVIEW.